中国组织工程研究 ›› 2019, Vol. 23 ›› Issue (11): 1794-1798.doi: 10.3969/j.issn.2095-4344.1114

• 组织构建综述 tissue construction review • 上一篇    下一篇

消退素E1抑制牙周炎及促进牙周组织重建的作用

蔡智国,刘  琪,都沙沙,杨  琨   

  1. (遵义医学院附属口腔医院牙周科,贵州省遵义市  563000)
  • 收稿日期:2018-12-05
  • 通讯作者: 刘琪,博士,主任医师,遵义医学院附属口腔医院牙周科,贵州省遵义市 563000
  • 作者简介:蔡智国,男,贵州省桐梓县人,汉族,遵义医学院在读硕士,主要从事2型糖尿病伴牙周炎研究。
  • 基金资助:

    国家自然科学基金(81860196),项目负责人:刘琪;国家自然科学基金(81760199),项目负责人:杨琨

Resolvin E1 inhibits periodontitis and promotes reconstruction of periodontal tissue

Cai Zhiguo, Liu Qi, Du Shasha, Yang Kun   

  1.  (Department of Periodontics, Hospital of Stomatology, Zunyi Medical University, Zunyi 563000, Guizhou Province, China)
  • Received:2018-12-05
  • Contact: Liu Qi, MD, Chief physician, Department of Periodontics, Hospital of Stomatology, Zunyi Medical University, Zunyi 563000, Guizhou Province, China
  • About author:Cai Zhiguo, Master candidate, Department of Periodontics, Hospital of Stomatology, Zunyi Medical University, Zunyi 563000, Guizhou Province, China
  • Supported by:

    the National Natural Science Foundation of China, No. 81860196 (to LQ) and 81760199 (to YK)

摘要:

文章快速阅读:

文题释义:
整合素:是广泛分布于细胞表面的跨膜蛋白,是细胞外基质的主要受体,介导细胞黏附。还能参与细胞增殖、分化、凋亡等多种活动,在细胞外基质和细胞骨架间提供生理性链接。其功能多样,在止血、血管形成、肿瘤、瘢痕、骨形成等众多疾病中起重要作用。
消退素E1(Resolvin E1,RvE1):是消退素家族中的主要成员之一。消退素主要源于二十碳五烯酸( Eicosapentaenoic acid,EPA)和二十二碳六烯酸(Docosahexaenoic acid,DHA)酶促转化,分为两大类:DHA在阿司匹林诱导下生成D系列消退素(Resolvin D,RvD),共有10余种异构体分子;EPA经酶促转化生成RvE,主要包括消退素E1、RvE2和RvE3,其中消退素E1是最先发现的,也是目前研究的热点。

摘要
背景:
E-系列消退素1(Resolvin E1,RvE1)能有效抑制炎性细胞浸润、诱导巨噬细胞吞噬体内有害物质等,促进炎症消退的作用,在实验性牙周炎病理转归中的效果已经得到初步证实。
目的:综述了消退素E1对牙周炎病理转归的促进作用及潜在的意义。
方法: 以“消退素E1,牙周炎,白细胞,血小板,活性氧,巨噬细胞,炎性因子,成骨细胞,破骨细胞”和“Resolvin E1, Periodontitis,leukocyte,platelet,reactive oxygen species,Macrophages,inflammatory factor,osteoblast,osteoclast”为关键词,检索PubMed数据库、中国生物医学文献库(CBM)和中国知识资源总库(CNKI)系列数据库1996年至2018年间收录的消退素E1与牙周炎相关文献33条,分析消退素E1对牙周炎修复和再生的研究进展。
结果与结论:目前临床途径尚不能有效解决牙周组织炎性反应、不可逆性丧失等难题,迫切需要有效途径控制炎症反应、恢复牙周重建。近年来大量研究显示消退素E1在牙周炎动物及细胞模型病理转归中具有良好的效果。消退素E1作为特定G蛋白偶联受体(趋化素受体23,白三烯B4受体1)的激动剂或部分激动剂,可以引发一系列细胞特异性反应,反向调节炎症进展,将可能为牙周炎病理转归提供新的方向。

中国组织工程研究杂志出版内容重点:组织构建;骨细胞;软骨细胞;细胞培养;成纤维细胞;血管内皮细胞;骨质疏松组织工程
ORCID: 0000-0003-0901-9237(蔡智国)

关键词: 牙周炎, 炎症因子, 牙周重建, 整合素, 细胞外基质, RvE1, E-系列消退素1, 吞噬体, 细胞骨架

Abstract:

BACKGROUND: Resolvin E1 can effectively inhibit inflammatory cell infiltration and induce macrophages to
swallow hazardous substances, and thus alleviates inflammation. Moreover, its effect on improving periodontitis has been preliminarily confirmed.
OBJECTIVE: To review the effects of resolvin E1 on promoting the pathologic regression of periodontitis and its potential significance.
METHODS: Articles addressing resolvin E1 and periodontitis published from 1996 to 2018 were retrieved from PubMed, CBM and CNKI databases. The keywords were “resolving E1, periodontitis, leukocyte, platelet, reactive oxygen species, macrophages, inflammatory factor, osteoblast, osteoclast” in English and Chinese, respectively. Thirty-three articles were included to analyze the research advance regarding resolvin E1 in the repair of periodontitis and tissue regeneration.
RESULTS AND CONCLUSION: At present, the clinical therapeutic pathway cannot solve the inflammatory reaction and irreversible loss of periodontal tissue effectively, so an effective way to control the inflammatory process and treat periodontitis is urgently needed. In recent years, a large number of studies have shown that resolvin E1 has a good therapeutic effect on periodontitis in animals and cell models. Resolvin E1, as an agonist or partial agonist of specific G protein-coupled receptor (chemokine receptor 23, leukotriene B4), can trigger a series of specific responses and reverse inflammation progression, which may provide a new direction for inversing the pathology of periodontal disease.

中国组织工程研究杂志出版内容重点:组织构建;骨细胞;软骨细胞;细胞培养;成纤维细胞;血管内皮细胞;骨质疏松组织工程

Key words: Periodontitis, Inflammation, Pathology, Tissue Engineering

中图分类号: